-The Times of India A day after Parliament worked up a lather over political cartoons in NCERT textbooks, MPs on Tuesday demanded a ban on indecent representation of women in advertisements. Demands ranged from calling an all-party meeting to setting up of a censor board for ads.  Responding to queries, I&B minister Ambika Soni said that the government was giving self-regulation a chance, but it was empowered and would take action if...

The controversy over a cartoon in an NCERT textbook sends a chill down the spine as it shows the extent to which the culture of intolerance has eaten into the vitals of our democratic polity. The cartoon in question shows B R Ambedkar sitting on a snail (Constitution) and flogging it while Jawaharlal Nehru too is brandishing a whip standing behind Ambedkar. It is clear that he is also aiming his...

Jatav residents of Ramgarh in U.P. resist attempts by members of a powerful community to grab their land by violent means. IN what could be considered one of the worst incidents of vendetta against Dalits in the National Capital Region (NCR), members of the Dalit Jatav community were beaten up brutally by some members of the dominant Gujjar community in Ramgarh village in the Greater Noida area of Uttar Pradesh...

Diluting women's share in marital property in the event of divorce, the government has sought to restrict the provision for `immoveable property' to residential assets, a move opposed by women's rights activists. The marriage amendment bill seeks to amend the Hindu Marriage Act, 1955, and the Special Marriage Act, 1954, legislating a women's right to marital property acquired during the subsistence of marriage. The amendment cleared by the Union Cabinet recently...

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...